tiprankstipranks
Trending News
More News >
Abbott Laboratories (DE:ABL)
XETRA:ABL
Germany Market

Abbott Laboratories (ABL) Ratios

Compare
13 Followers

Abbott Laboratories Ratios

DE:ABL's free cash flow for Q3 2025 was $0.56. For the 2025 fiscal year, DE:ABL's free cash flow was decreased by $ and operating cash flow was $0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.70 1.64 1.63 1.85 1.72
Quick Ratio
1.24 1.16 1.23 1.46 1.30
Cash Ratio
0.52 0.50 0.64 0.75 0.57
Solvency Ratio
0.52 0.26 0.27 0.27 0.20
Operating Cash Flow Ratio
0.63 0.52 0.62 0.80 0.66
Short-Term Operating Cash Flow Coverage
6.78 6.72 4.26 13.97 35.91
Net Current Asset Value
$ -8.08B$ -11.72B$ -12.31B$ -14.93B$ -19.10B
Leverage Ratios
Debt-to-Assets Ratio
0.15 0.22 0.24 0.25 0.27
Debt-to-Equity Ratio
0.25 0.41 0.48 0.53 0.60
Debt-to-Capital Ratio
0.20 0.29 0.33 0.35 0.37
Long-Term Debt-to-Capital Ratio
0.19 0.26 0.28 0.33 0.36
Financial Leverage Ratio
1.65 1.90 2.03 2.10 2.21
Debt Service Coverage Ratio
9.34 5.63 4.19 9.33 11.52
Interest Coverage Ratio
17.21 10.17 22.30 17.19 10.71
Debt to Market Cap
0.06 0.08 0.09 0.07 0.10
Interest Debt Per Share
7.66 9.52 10.32 10.98 11.36
Net Debt to EBITDA
0.50 0.85 0.63 0.72 1.46
Profitability Margins
Gross Profit Margin
53.98%55.18%56.15%56.97%56.65%
EBIT Margin
19.59%18.20%20.31%20.30%15.93%
EBITDA Margin
24.93%26.44%28.36%29.58%25.40%
Operating Profit Margin
17.70%16.15%19.16%19.56%15.48%
Pretax Profit Margin
18.56%16.61%19.03%19.06%14.36%
Net Profit Margin
31.88%14.27%15.88%16.42%12.99%
Continuous Operations Profit Margin
31.88%14.27%15.88%16.42%12.92%
Net Income Per EBT
171.75%85.88%83.47%86.12%90.48%
EBT Per EBIT
104.87%102.87%99.33%97.46%92.74%
Return on Assets (ROA)
16.60%7.82%9.31%9.40%6.20%
Return on Equity (ROE)
28.24%14.83%18.90%19.75%13.71%
Return on Capital Employed (ROCE)
11.15%10.91%14.19%13.57%8.83%
Return on Invested Capital (ROIC)
18.79%9.17%11.36%11.50%7.89%
Return on Tangible Assets
25.59%14.05%16.83%18.03%13.21%
Earnings Yield
6.24%3.00%3.60%2.83%2.32%
Efficiency Ratios
Receivables Turnover
4.22 6.11 7.02 6.64 5.40
Payables Turnover
4.89 4.19 4.15 4.21 3.80
Inventory Turnover
3.01 2.74 3.10 3.59 2.99
Fixed Asset Turnover
3.81 3.56 4.76 4.81 3.83
Asset Turnover
0.52 0.55 0.59 0.57 0.48
Working Capital Turnover Ratio
4.12 4.32 4.18 4.38 5.19
Cash Conversion Cycle
133.33 105.94 81.85 69.72 93.58
Days of Sales Outstanding
86.57 59.74 51.99 54.97 67.65
Days of Inventory Outstanding
121.36 133.41 117.71 101.54 121.93
Days of Payables Outstanding
74.59 87.21 87.85 86.80 96.00
Operating Cycle
207.92 193.15 169.70 156.51 189.58
Cash Flow Ratios
Operating Cash Flow Per Share
5.21 4.19 5.47 5.93 4.46
Free Cash Flow Per Share
3.95 2.92 4.45 4.87 3.23
CapEx Per Share
1.26 1.27 1.01 1.06 1.23
Free Cash Flow to Operating Cash Flow
0.76 0.70 0.81 0.82 0.72
Dividend Paid and CapEx Coverage Ratio
1.46 1.26 1.88 2.07 1.67
Capital Expenditure Coverage Ratio
4.14 3.30 5.39 5.59 3.63
Operating Cash Flow Coverage Ratio
0.70 0.46 0.54 0.55 0.40
Operating Cash Flow to Sales Ratio
0.21 0.18 0.22 0.24 0.23
Free Cash Flow Yield
3.10%2.65%4.05%3.46%2.95%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.02 33.35 27.76 35.33 43.19
Price-to-Sales (P/S) Ratio
5.08 4.76 4.41 5.80 5.61
Price-to-Book (P/B) Ratio
4.40 4.94 5.25 6.98 5.92
Price-to-Free Cash Flow (P/FCF) Ratio
32.22 37.73 24.66 28.89 33.91
Price-to-Operating Cash Flow Ratio
24.56 26.29 20.09 23.72 24.57
Price-to-Earnings Growth (PEG) Ratio
-129.15 -2.05 -36.74 0.61 1.99
Price-to-Fair Value
4.40 4.94 5.25 6.98 5.92
Enterprise Value Multiple
20.89 18.84 16.18 20.33 23.54
Enterprise Value
228.31B 199.85B 200.30B 259.02B 206.94B
EV to EBITDA
20.89 18.84 16.18 20.33 23.54
EV to Sales
5.21 4.98 4.59 6.01 5.98
EV to Free Cash Flow
33.01 39.50 25.67 29.95 36.15
EV to Operating Cash Flow
25.04 27.52 20.91 24.59 26.19
Tangible Book Value Per Share
12.41 3.65 2.08 0.03 -3.12
Shareholders’ Equity Per Share
29.13 22.26 20.93 20.17 18.49
Tax and Other Ratios
Effective Tax Rate
-0.72 0.14 0.17 0.14 0.10
Revenue Per Share
25.07 23.13 24.90 24.27 19.52
Net Income Per Share
7.99 3.30 3.95 3.98 2.54
Tax Burden
1.72 0.86 0.83 0.86 0.90
Interest Burden
0.95 0.91 0.94 0.94 0.90
Research & Development to Revenue
0.07 0.07 0.07 0.06 0.07
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.01 0.02
Income Quality
0.65 1.27 1.38 1.49 1.76
Currency in USD